Envestnet Portfolio Solutions, Inc. Teva Pharmaceutical Industries LTD Transaction History

Envestnet Portfolio Solutions, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	SELL	$14.67 - $22.01 $6,762 - $10,146	-461 Reduced 4.4%	10,007 $153,000
Q4 2024 Feb 10, 2025	SELL	$16.43 - $22.77 $43,293 - $59,998	-2,635 Reduced 20.11%	10,468 $230,000
Q3 2024 Oct 31, 2024	BUY	$15.81 - $18.96 $24,379 - $29,236	1,542 Added 13.34%	13,103 $236,000
Q2 2024 Jul 16, 2024	BUY	$12.78 - $17.4 $147,749 - $201,161	11,561 New	11,561 $187,000

668

623M

30.8M

18.5M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $28.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Envestnet Portfolio Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Envestnet Portfolio Solutions, Inc. with notifications on news.